Skip Navigation LinksVaccine Adverse Event Reporting System. The image includes photgraphs of a couple, a doctor, a women and child, a baby, and an elderly.
     

CDC

Food and Drug Administration (FDA)

Introduction

Frequently Asked Questions

Bibliography

Contact Information

VAERS Form
(PDF 23K)

VAERS Web Submission

VAERS Data

VAERS Continuing Education

Publications

Links

Privacy Policies & Disclaimers

Call VAERS at
1-800-822-7967

VAERS Bibliography - February 2003

  1. Accelerated Measles Control—Cambodia, 1999-2002. MMWR Morb.Mortal.Wkly.Rep.  1-10-2003, 52 (1): 4-6.

  2. Smallpox Vaccine Med.Lett.Drugs Ther.  1-6-2003, 45 (1147): 1-4.

  3. ACOG Committee Opinion. Immunization During Pregnancy Obstet.Gynecol.  2003, 101 (1): 207-212.

  4. Do You Know Who Will Be Vaccinated at Your ED? ED Manag.  2003, 15 (1): 5-6, suppl. 1-2

  5. Is There a Link Between MMR Vaccine and Autism?...and an Expert’s Commentary Child Health Alert.  2002 Dec, 20:1-2.

  6. Smallpox Vaccination: Pediatric Academy Perspective Child Health Alert.  2002 Nov, 20:3-4.

  7. Surveillance for Safety After Immunization: Vaccine Adverse Event Reporting System (VAERS)— United States, 1991--2001 MMWR Surveillance Summaries, January 24, 2003 / 52(ss01);1-24.

  8. [Vaccinations of Adults: Whom to Vaccinate, and How. Proceedings of an International Congress. Gibraltar, April 13-16, 2002] Ann.Ig  2002, 14 (3 Suppl 3): 1-117.

  9. Alswede, M.  An Analysis of the Proposed National Strategy for Smallpox Vaccination of Health Care Workers Air Med.J  2003, 22 (1): 22-25.

  10. Baltimore, R. S. and Jenson, H. B.  Editorial Review: New Recommendations for Influenza Vaccination for Children and Pregnant Women Curr.Opin.Pediatr.  2003, 15 (1): 74-76.

  11. Banz, K., Wagenpfeil, S., Neiss, A., Goertz, A., Staginnus, U., Vollmar, J., and Wutzler, P.  The Cost-Effectiveness of Routine Childhood Varicella Vaccination in Germany Vaccine  3-7-2003, 21 (11-12): 1256-1267.

  12. Baudier, F., Allemand, H., and Lancry, P. J.  [Threats on Vaccination] Rev.Epidemiol.Sante Publique  2002, 50 (6): 505-508.

  13. Bernstein, D. I., Yan, L., Treanor, J., Mendelman, P. M., and Belshe, R.  Effect of Yearly Vaccinations With Live, Attenuated, Cold-Adapted, Trivalent, Intranasal Influenza Vaccines on Antibody Responses in Children Pediatr.Infect.Dis.J  2003, 22 (1): 28-34.

  14. Campbell, M. J. and Jiwa, M.  Educational Outreach to Improve Vaccination Uptake Br.J Gen.Pract.  2002, 52 (485): 1021-1022.

  15. Campos, W. and Jalaludin, B. B.  Predictors of Influenza Vaccination Amongst Australian Nurses Aust.J Adv.Nurs.  12-20-2002, 20 (2): 19-21.

  16. Christenson, B. and Lundbergh, P.  Comparison Between Cohorts Vaccinated and Unvaccinated Against Influenza and Pneumococcal Infection Epidemiol.Infect.  2002, 129 (3): 515-524.

  17. Crump, S. C. and Oxley, M.  Society of Homeopaths Does Not Advise Against Vaccination BMJ  1-18-2003, 326 (7381): 164.

  18. Desai, V. K., Kapadia, S. J., Kumar, P., and Nirupam, S.  Impact Assessment of Mass Measles Vaccination Indian J Pediatr.  2002, 69 (12): 1037-1040.

  19. Dodds, W. J.  Advocate for Serologic Testing After Vaccination J Am.Vet.Med.Assoc.  1-15-2003, 222 (2): 149-150.

  20. Egede, L. E. and Zheng, D.  Racial/Ethnic Differences in Adult Vaccination Among Individuals With Diabetes Am.J Public Health  2003, 93 (2): 324-329.

  21. Ehreth, J.  The Global Value of Vaccination Vaccine  1-30-2003, 21 (7-8): 596-600.

  22. Enserink, M.  Bioterrorism. New Look at Old Data Irks Smallpox-Eradication Experts Science  1-10-2003, 299 (5604): 181.

  23. Hall, A. J.  Vaccination Politics Trop.Med.Int.Health  2003, 8 (1): 1-2.

  24. Hostler, D., Milspaw, J., and Paris, P. M.  Pneumococcal Vaccination: An Opportunity for Emergency Medical Services Prehosp.Emerg.Care  2003, 7 (1): 125-135.

  25. Janaszek, W., Gay, N. J., and Gut, W.  Measles Vaccine Efficacy During an Epidemic in 1998 in the Highly Vaccinated Population of Poland Vaccine  1-17-2003, 21 (5-6): 473-478.

  26. Ki, M., Park, T., Yi, S. G., Oh, J. K., and Choi, B.  Risk Analysis of Aseptic Meningitis After Measles-Mumps-Rubella Vaccination in Korean Children by Using a Case-Crossover Design Am.J Epidemiol.  1-15-2003, 157 (2): 158-165.

  27. Kuroiwa, C., Xayyavong, P., Vongphrachanh, P., Khampapongpane, B., Yamanaka, M., and Nakamura, S.  Difficulties in Measles Elimination: Prevalence of Measles Antibodies Before and After Mass Vaccination Campaign in Laos Vaccine  1-17-2003, 21 (5-6): 479-484.

  28. Lyratzopoulos, G., Aston, R., Bailey, K., Flitcroft, J., and Clarke, H.  Accuracy of Routine Data on MMR Vaccination Coverage and Validity of Parental Recall of Vaccination Commun.Dis.Public Health  2002, 5 (4): 305-310.

  29. Montes, M., Cilla, G., Artieda, J., Vicente, D., and Basterretxea, M.  Mumps Outbreak in Vaccinated Children in Gipuzkoa (Basque Country), Spain Epidemiol.Infect.  2002, 129 (3): 551-556.

  30. 30.  Moynihan, R.  Health Professionals Challenge US Smallpox Vaccination Plan BMJ  1-25-2003, 326 (7382): 179.

  31. Musharrafieh, U. M., Nuwayhid, I. A., Hamadeh, G. N., Steitieh, S. W., and Bizri, A. R.  Immunity to Chickenpox Among School Adolescents in Lebanon and Options for Vaccination Epidemiol.Infect.  2002, 129 (3): 607-615.

  32. Niemann, T.  Vaccination Information Reaches Audience J Am.Vet.Med.Assoc.  2-1-2003, 222 (3): 283.

  33. Rubins, K. and Relman, D. A.  Images in Clinical Medicine. Progression of the Lesion at the Site of Inoculation After Smallpox Vaccination N.Engl.J Med.  1-30-2003, 348 (5): 414.

  34. Salleras, L., Dominguez, A., and Cardenosa, N.  Impact of Mass Vaccination With Polysaccharide Conjugate Vaccine Against Serogroup C Meningococcal Disease in Spain Vaccine  1-30-2003, 21 (7-8): 725-728.

  35. Salleras, L., Dominguez, A., and Cardenosa, N.  Dramatic Decline of Serogroup C Meningococcal Disease in Catalonia (Spain) After a Mass Vaccination Campaign With Meningococcal C Conjugated Vaccine Vaccine  1-30-2003, 21 (7-8): 729-733.

  36. Schmidt, K. and Ernst, E.  MMR Vaccination Advice Over the Internet Vaccine  3-7-2003, 21 (11-12): 1044-1047.

  37. Schmitt, H. J., Booy, R., Weil-Olivier, C., Van Damme, P., Cohen, R., and Peltola, H.  Child Vaccination Policies in Europe: A Report From the Summits of Independent European Vaccination Experts Lancet Infect.Dis.  2003, 3 (2): 103-108.

  38. Schofield, C.  Who Should Receive the Influenza Vaccine? Nursing  2002, 32 (11 Pt 1): 24.

  39. Singh, M. B. and Bhalla, P. L.  Hypoallergenic Derivatives of Major Grass Pollen Allergens for Allergy Vaccination Immunol.Cell Biol.  2003, 81 (1): 86-91.

  40. Smithson, R.  Varicella Vaccination—An Ethical Issue Commun.Dis.Public Health  2002, 5 (4): 343.

  41. Stewart, S., Murray, S. B., and Skull, S. A.  Evaluation of Health-Care Worker Vaccination in a Tertiary Australian Hospital Intern.Med.J  2002, 32 (12): 585-592.

  42. Taneja, V.  Hib Vaccination Controversy and the Declaration of Commercial Interest Indian Pediatr.  2003, 40 (1): 75-76.

  43. Toscani, L., Gauthey, L., and Robert, C. F.  The Information Network of Senior Citizens in Geneva, Switzerland, and Progress in Flu Vaccination Coverage Between 1991 and 2000 Vaccine  1-17-2003, 21 (5-6): 393-398.

  44. Trotter, C., Borrow, R., Andrews, N., and Miller, E.  Seroprevalence of Meningococcal Serogroup C Bactericidal Antibody in England and Wales in the Pre-Vaccination Era Vaccine  3-7-2003, 21 (11-12): 1094-1098.

  45. van den, Hof S., Wallinga, J., Widdowson, M. A., and Conyn-van Spaendonck, M. A.  Options for Improvement of the Dutch Measles Vaccination Schedule Vaccine  1-30-2003, 21 (7-8): 721-724.

  46. Van Der, Aa A., Hellings, N., Medaer, R., Gelin, G., Palmers, Y., Raus, J., and Stinissen, P.  T Cell Vaccination in Multiple Sclerosis Patients With Autologous CSF-Derived Activated T Cells: Results From a Pilot Study Clin.Exp.Immunol.  2003, 131 (1): 155-168.

  47. Vazquez, J. A.  [Inmunisation: Leaps into the Future. Vaccination for Bacterial Meningitis: Reality or Myth?] Aten.Primaria  12-15-2002, 30 (10): 643-647.

  48. Wise, R. P., Braun, M. M., Seward, J. F., Mootrey, G. T., Shields, K. E., Salive, M. E., and Krause, P. R.  Pharmacoepidemiologic Implications of Erroneous Varicella Vaccinations in Pregnancy Through Confusion With Varicella Zoster Immune Globulin Pharmacoepidemiol.Drug Saf  2002, 11 (8): 651-654.

  49. Wong, G.  Educational Outreach to Improve Vaccination Uptake Br.J Gen.Pract.  2002, 52 (485): 1021.

  50. Zimmerman, R. K.  Recommended Childhood and Adolescent Immunization Schedule, United States, 2003 and Update on Childhood Immunizations Am.Fam.Physician  1-1-2003, 67 (1): 188-6.

  51. Zimmerman, R. K., Santibanez, T. A., Janosky, J. E., Fine, M. J., Raymund, M., Wilson, S. A., Bardella, I. J., Medsger, A. R., and Nowalk, M. P.  What Affects Influenza Vaccination Rates Among Older Patients? An Analysis From Inner-City, Suburban, Rural, and Veterans Affairs Practices Am.J Med.  2003, 114 (1): 31-38.

Back to Top